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Abstract
Aims: To present a new approach for estimating the ‘‘true prevalence’’ of malaria and apply it to datasets from Peru,
Vietnam, and Cambodia.
Methods: Bayesian models were developed for estimating both the malaria prevalence using different diagnostic tests
(microscopy, PCR & ELISA), without the need of a gold standard, and the tests’ characteristics. Several sources of
information, i.e. data, expert opinions and other sources of knowledge can be integrated into the model. This approach
resulting in an optimal and harmonized estimate of malaria infection prevalence, with no conflict between the different
sources of information, was tested on data from Peru, Vietnam and Cambodia.
Results: Malaria sero-prevalence was relatively low in all sites, with ELISA showing the highest estimates. The sensitivity of
microscopy and ELISA were statistically lower in Vietnam than in the other sites. Similarly, the specificities of microscopy,
ELISA and PCR were significantly lower in Vietnam than in the other sites. In Vietnam and Peru, microscopy was closer to the
‘‘true’’ estimate than the other 2 tests while as expected ELISA, with its lower specificity, usually overestimated the
prevalence.
Conclusions: Bayesian methods are useful for analyzing prevalence results when no gold standard diagnostic test is
available. Though some results are expected, e.g. PCR more sensitive than microscopy, a standardized and context-
independent quantification of the diagnostic tests’ characteristics (sensitivity and specificity) and the underlying malaria
prevalence may be useful for comparing different sites. Indeed, the use of a single diagnostic technique could strongly bias
the prevalence estimation. This limitation can be circumvented by using a Bayesian framework taking into account the
imperfect characteristics of the currently available diagnostic tests. As discussed in the paper, this approach may further
support global malaria burden estimation initiatives.
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Introduction
Though malaria remains a major public health problem
worldwide, particularly for the poorest countries [1], a decreasing
trend of its burden, including in sub-Saharan Africa, has been
recently reported [2]. Such a change has been attributed to large-
scale indoor residual spraying (IRS) campaigns [3] to IRS together
with the distribution of insecticide-treated bed net (ITN) [4], and
to the introduction of artemisinin-based combination treatments
(ACT) together or not with ITNs [5]. These encouraging results
are probably due to the increased attention malaria is receiving
and the corresponding mobilization of resources. There has also
been a recent and radical shift from control to elimination with
eventually eradication as a goal, first proposed by the Melinda and
Bill Gates Foundation in 2007 and then rapidly endorsed by the
World Health Organisation (WHO) and the Roll Back Malaria
(RBM) Partnership. The latter developed a Global Malaria Action
Plan (GMAP) for a substantial and sustained reduction of the
malaria burden in the near and mid-term, and when new tools
would make it possible, the eventual global eradication in the long
term (http://www.rollbackmalaria.org/gmap/). Within this con-
text, being able to estimate with confidence the malaria prevalence
in a given country/district is essential for targeting control/
elimination efforts, monitoring the progress towards established
goals, e.g. the Millennium Development Goals, and documenting
achievements [6]. Without an accurate estimation, established
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and reaching objectives, ordering diagnostics and interventions, and
attracting funding agencies that are often result-focused. Microsco-
py is often taken as the gold standard for diagnosis. However,
considering that its sensitivity is limited by low parasite densities, a
common feature in low endemic areas, it is a rather imperfect one.
In addition, the technique is laborious and requires experienced
laboratory technicians, both for the staining and for the reading of
the slides so that often, in field conditions, its sensitivity is evenlower
than expected [7,8]. Over the past two decades, alternative
diagnostic tests have been developed [9] and their sensitivity and
specificity have been evaluated against the less-than-optimal
reference microscopy test [10–14]. In a different approach, no gold
standard was designated [9] and the evaluation was done according
to the methods described by Hui and Walter [15] that assumed a
single, true but unobserved prevalence for each study and common
sensitivity and specificity of each diagnostic test across the group of
studies [9]. Such assumption may not be true as the sensitivity and
specificity may vary accordingto external factors, which canbe field
related, e.g., sampling season, age, presence of other cross-reacting
diseases [16,17], and laboratory related factors, e.g., in case of
microscopy the experience of the readers [9].
The other assumption made by Hui and Walter is that
diagnostic tests are conditionally independent given the true (but
latent) prevalence of infection. From a practical point of view, such
assumptions can be incorrect and several approaches to circum-
vent them have been suggested [18,19].
The performance of different diagnostic techniques depends on the
malaria species, the parasite density, previous treatment, gametocy-
taemia and the quality of the diagnostic method [20]. Test sensitivity
and specificity, as traditionally defined, are thus purely theoretical
concepts, not necessarily established inthe conditions where the test is
actually used. In a given setting, the local characteristics (season,
presence of cross-reacting organisms, experience of the laboratory
technicians) should be considered when obtaining an ‘‘adjusted’’
estimate of the test’s sensitivity and specificity [21]. The purpose of
this paper is to present a methodological framework for estimating a
‘‘true prevalence’’ and evaluating optimally, in a single analysis
different malaria diagnostic tests.
Given that the diagnostic tests’ characteristics, i.e. sensitivity and
specificity, can be variable and context-specific and that no gold
standard is available, combining all available information can be an
interesting approach. Indeed, results obtained by different diagnostic
tests are related more or less closely to the ’’true’’ malaria prevalence
so that it may be useful to estimate it by considering the results
obtained by all tests available. As already shown [19], this is only
possible by combining test results with expert opinions on the tests’
characteristics. In addition, conflicts can be checked by identifying
anydifference occurringbothamongexpertsandbetweentheexpert
opinions and the actual results, leading to the optimal estimation of
the ‘‘true’’ malaria prevalence and of the context-specific diagnostic
test characteristics. New diagnostic tests could be easily inserted into
this model and their unknown characteristics estimated. With this
approach, the prevalence estimations can be optimized (i.e. ‘‘true’’)
and made comparable across different settings, i.e. a site specific
analysis would be possible. This is important as there is the need of
standardizing malaria prevalence estimates.
Materials and Methods
Estimating the malaria prevalence without a reference
(gold standard) diagnostic test
The concept of analyzing multiple diagnostic tests can be
explained by as an example assuming that only two diagnostic tests
are available. The model also assumes that there is a single true
but unknown prevalence of P. falciparum infection, i.e., a case is
defined as a currently infected individual, and that the sensitivity
and specificity of the two diagnostic tests are unknown. The class
of models in which the infection status is unknown is sometimes
referred to as latent class models, i.e. the infection status is latent as
it exists but is not evident or detected by a diagnostic test. In the
analysis of the diagnostic test characteristics, the following
notations can be used (with j=1, 2…indicating diagnostic test 1,
diagnostic test 2,…) and ‘‘|’’meaning conditional on (or ‘‘given’’):
– infection status D: D=1: infected, D=0: not infected
– test result: Yj=1: positive, Yj=0: negative
– sensitivity of test j (Sej): P(Yj=1 | D=1)
– specificity of test j (Spj): P(Yj=0 | D=0)
– prevalence of infection in the study population (p): P (D=1)
Assuming independence of Y1 and Y2 and given the infection
status, then:
P(Y1~1,Y2~1)~
P(D~1)   P(Y1~1, Y2~1jD~1)zP(D~0) 
P(Y1~1,Y2~1D ~0)~(due to independence) j
PD ~1 ðÞ   PY 1 ~1jD~1Þ ð  PY 2 ~1jD~1Þ ð zPD ~0 ðÞ  
PY 1 ~1jD~0Þ ð  PY 2 ~1jD~0Þ ð ~
p   Se1   Se2z(1{p)   (1{Sp1)   (1{Sp2)
Expanding this to all possible outcomes of two tests’ results in a
set of 4 equations (=model):
P(Y1~1,Y2~1)~p   Se1   Se2z(1{p)   (1{Sp1)   (1{Sp2)
P(Y1~1,Y2~0)~p   Se1   (1{Se2)z(1{p)   (1{Sp1)   Sp2
P(Y1~0,Y2~1)~p   (1{Se1)   Se2z(1{p)   Sp1   (1{Sp2)
P(Y1~0,Y2~0)~p   (1{Se1)   (1{Se2)z(1{p)   Sp1   Sp2
This provides 3 independent equations (because the sum of all
left-side proportions in the equations sum to 1) and 5 parameters
to estimate. In mathematical terms this is consequently not
estimable but it would be when fixing in a deterministic way some
parameters or using in a probabilistic way prior information for
some of them, e.g., inclusion of the experts’ opinions. This
approach allows the incorporation of knowledge, such as historical
information from experiments similar or related to the one under
study, an educated guess about outcomes or even subjective beliefs
of the investigator (i.e. expert opinion). These prior probabilities
are then updated in a rational way after data collection. Bayesian
Malaria Prevalence: A Bayesian Approach
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many applications in different areas. Powerful computers and
software packages as R and WinBUGS are now common and
Bayesian statistics theory is now commonly applied in the
development of powerful algorithms and models that process data
in new ways [22].
Extending the example to 3 tests will result in 7 independent
equations and 7 parameters to estimate, meaning that the
equations are ‘‘estimable’’. With 4 or more tests, there are more
equations than parameters and the number of estimable
parameters exceeds that to estimate. The model (set of equations)
is then over specified. Table 1 shows for 1 to 5 tests, the maximum
number of estimable parameters and the number of parameters to
be estimated in the absence or presence of conditional indepen-
dence as a function of the number of tests per subject.
For many years, it has been assumed that two (or more)
diagnostic tests are conditionally independent given the true (but
latent) prevalence of infection [15,23], i.e. (see before), P(Y1=1,
Y2=1 | D=1) = P(Y1=1 | D=1)*P(Y2=1 | D=1), and that
this applies to other possible test results and to disease/infection-
free subjects. However, when the two diagnostic tests have a
similar biological basis, as is often the case, the conditional
independence assumption is untenable [18]. It is possible to insert
conditional dependence into the model in several ways [19], but
this always entails the need to estimate more parameters then the
available equations permit (even with four or more tests).
Consequently, the need for a Bayesian approach (i.e. prior
information) in these circumstances is even more relevant.
The Bayesian philosophy and diagnostic testing
Since none of the diagnostic tests included in this study can be
considered as the gold standard, a Bayesian approach can be used,
i.e. combining data with prior information to estimate the malaria
prevalence and the test characteristics. In this paper, a
multinomial Bayesian model adapted from Berkvens et al. [19]
was used (WinBUGS-code available upon request). This method
has been validated for a number of pathogens, e.g. cysticercosis
[24] and campylobacter [25]. Prior distributions on the param-
eters from experts’ opinions can be obtained in several ways
[26,27] but the approach used in [19] is well adapted to the way
experts think about the test’s diagnostic performances as they often
know them in relation to a reference test (very often one with a
very high specificity). The approach has certain mathematical
advantages as well. The final priors of the model are presented in
Table 2.
Within the multi-diagnostic Bayesian framework, there are
mostly more parameters to estimate than equations, especially
when conditional dependence is taken into account. This requires
the inputs from experts for some of the parameters, i.e. the
sensitivity and specificity. They are asked to provide both their
estimations and an expression of uncertainty (i.e. credibility
intervals). In this study, prior information on the test character-
istics was obtained from four experts at the Institute of Tropical
Medicine, Antwerp, Belgium, and was expressed as conditional
probabilities.
The match between the experts’ opinions, any other prior
information and the observations can be evaluated through the
Bayesian p-value (Bayes-p), the Deviance Information Criterion
Table 1. Maximum number of estimable parameters, number
of parameters to be estimated in the absence and presence of
conditional independence as a function of the number of
tests per subject.
Number
of tests
Maximum
number of
estimable
parameters
Parameters
to be estimated
under conditional
dependence
Parameters
to be estimated
under conditional
independence
11 3 3
23 7 5
3 7 15 7
41 5 3 1 9
53 1 6 3 1 1
doi:10.1371/journal.pone.0016705.t001
Table 2. Prior information (uniform distributions) based on expert opinion.
Parameters Constrains
Sensitivity of the microscopy for the detection of infected individuals [0.7–1]
Specificity of the microscopy for the detection of non-infected individuals [0.9–1]
Probability to have a positive result for the ELISA if the individual is infected and positive for the microscopy [0.7–1]
Probability to have a positive result for the ELISA if the individual is infected and negative for the microscopy [0–1]
Probability to have a negative result for the ELISA if the individual is not infected and negative for the microscopy [0–1]
Probability to have a negative result for the ELISA if the individual is not infected and positive for the microscopy [0–1]
Probability to have a positive result for the PCR if the individual is infected and positive for the microscopy and the ELISA** [0.98–1]
Probability to have a positive result for the PCR if the individual is infected, positive for the microscopy and negative for the ELISA** [0.98–1]
Probability to have a positive result for the PCR if the individual is infected, negative for the microscopy and positive for the ELISA** [0.75–1]
Probability to have a positive result for the PCR if the individual is infected and negative for the microscopy and the ELISA** [0.75–1]
Probability to have a negative result for the PCR if the individual is not infected and negative for the microscopy and the ELISA** [0.95–1]
Probability to have a negative result for the PCR if the individual is not infected, negative for the microscopy and positive for the ELISA** [0.9–1]
Probability to have a negative result for the PCR if the individual is not infected, positive for the microscopy and negative for the ELISA** [0.9–1]
Probability to have a negative result for the PCR if the individual is not infected and positive for the microscopy and the ELISA** [0.9–1]
ELISA=Enzyme-Linked Immunosorbent Assay; PCR=Polymerase Chain Reaction.
**for Vietnam. Peru Iquitos and Peru Jaen only.
doi:10.1371/journal.pone.0016705.t002
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the model (pD) [19] which quantifies the impact of the constraints.
The correspondence between the pD and DIC values calculated
in the posterior mean of the multinomial probabilities and in the
posterior mean of the parameters of the model (parent nodes) was
checked. The trend of the Bayes-p [29] towards 0 when narrowing
the constraints on the estimates was determined.
The analysis was done in WinBUGS 4 and R 2.11.0. Three
chains, 20,000 iterations, following a burn-in of 5,000 were used to
assess the convergence of the results. The sensitivity and specificity
of the diagnostic tests and the malaria prevalence were estimated
by the model. The prevalence was defined as the proportion of
individuals infected by P. falciparum. The credibility intervals for
differences between the characteristics of the diagnostic tests in
different conditions with both limits having the same sign (i.e., zero
not included in the interval) can be interpreted as the equivalent of
a significant difference in a frequentist approach.
Diagnostic Tests Used
To detect specific antibodies against P. falciparum infections, an
antibody detection ELISA test was used using a specific antigen for
Plasmodium. falciparum (GLURP, conserved region R2) (Claes et al.
2010, submitted). For the detection of the specific Plasmodium
species DNA, a semi-nested multiplex PCR was used as described
by [30]. Samples showing a specific P. falciparum amplicon of
395 bp were considered positive while samples showing no
amplification or a PCR product of a different size (indicating
infection with another species) were considered negative. Samples
showing mixed infections of P. falciparum with other species were
considered positive. A parasitological diagnosis was performed
using standard microscopic reading of thick and thin blood films.
Details of slide preparation and reading procedures were
published elsewhere [31]. Samples were considered negative when
no asexual form was found after reading 1000WBC.
Study areas and ethical clearance
The 3 diagnostic tests were performed on blood samples
obtained from individuals living in 3 different countries, Vietnam,
Cambodia and Peru, the latter contributing with 2 sites while
samples from Cambodia were obtained in the same site but at 2
different time points. Therefore, 5 different datasets were used for
this analysis. All the named institutional review boards or ethics
committees specifically approved the study. Each study protocol
had been reviewed by the ethical committee of the ITM and
University of Antwerp as well as by respective national ethical
committees for each country (Peru, Cambodia, Vietnam).
Vietnam
Samples were collected during a cross sectional survey carried
out in November-December 2004 (end of the rainy season) in 33
rural communities located in 2 forested districts of Ninh Thuan
Province, Central Vietnam. Malaria transmission in the study area
was relatively low but perennial with 2 peaks (May-June &
October-November), with the sylvatic species Anopheles. dirus sensu
stricto being the main vector. The survey was part of a community-
based trial aimed at determining the effectiveness of long-lasting
insecticidal hammocks (LLIH) in preventing forest malaria [31].
Following the trial protocol, over 4,000 individuals (aged 2 to 60
years) were randomly selected from the census for the survey. The
trial protocol was approved by the Ethical Committees of the
National Institute of Malariology, Parasitology & Entomology,
Hanoi, Vietnam, and by the Institutional Review Board of the
Institute of Tropical Medicine and the Ethical Committee of the
University Hospital, both in Antwerp, Belgium.
Peru (Jaen)
The cross sectional survey was carried out in April-May 2006
(end of rainy season), in the peri-urban area of Jaen city, the
capital of Cajamarca Dept, Northern Peru. Households were
chosen randomly and all family members screened for malaria
parasites in order to reach a total sample size of 504 individuals
(age 6 months–50 years). This study was submitted for ethical
approval to the Ethics Review Board of the Universidad Peruana
Cayetano Heredia, Lima, Peru (Code SIDISI: 051675).
Peru (Iquitos)
This study was carried out in several communities (peri-urban &
rural) near Iquitos City, the capital of Loreto Department, situated
in the Peruvian Amazon, within the activities of the Multi-Country
Malaria Project ‘‘Malaria control on the cross border areas of the
Andean Region: A community based approach’’ - PAMAFRO
together with the National Malaria Control Program. Blood
samples were collected in all febrile patients presenting at their
health posts or health centers between November and December
2006 (beginning of the rainy season). This study was submitted for
ethical approval to the Ethical Review Committee of the
Universidad Peruana Cayetano Heredia (EC-UPCH), Lima.
Cambodia
A malariometric surveys were conducted in August-September
(rainy season – survey 1 (S1)), and in November-December 2005
(end of rainy season - survey2 (S2)) in 12 villages located in the
forest areas of north-east (Rattanakiri -6 villages) and west
Cambodia (Pailin -3 villages; Pursat 3 villages). A representative
sample of the inhabitants of each village has been examined (tick
film, filter papers, questionnaire, symptoms). The protocol was
approved by the Commission of Medical Ethics of the Prince
Leopold Institute of Tropical Medicine (Ref: 05 10 4 491).
In all surveys, selected individuals were explained in the local
language the study objectives, methodology, risks and benefits, and
were asked to give their informed consent. In both Peruvian
studies, written informed consent was given by all study
participants.
In Vietnam and Cambodia, verbal informed consent was given
by all study participants. The institutional review board of the
Institute of Tropical Medicine approved this verbal consent.
Positive patients were treated according to the national
guidelines. Blood samples for microscopic examination (thick
and thin blood film) and for later genotyping and serology on filter
paper (Whatman filter paper grade 3) were collected. PCR analysis
was not carried out on the Cambodia samples.
Results
The apparent prevalence was relatively low in all sites, with
ELISA giving the highest estimates (Table 3), as confirmed by the
higher number of positive individuals for ELISA among all
positives by any test (Table 4). According to the Bayes-p
estimations, the initial prior information was in agreement with
the tests’ results for all countries except for Vietnam, where both
the constraint on the sensitivity of the microscopy and the experts’
opinion on the probability of a positive ELISA in an infected
individual with a positive blood slide, did not match the actual
results. Both were relaxed from a [0.7–1] to a [0.4–1] uniform
distribution (implying less knowledge or more uncertainty than the
initial information) to allow agreement between the prior
information and the Vietnamese data. After this adaptation all
models converged.
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characteristics in the 5 different conditions. Notably, the
sensitivities of microscopy and ELISA were statistically lower in
Vietnam than in Peru-Iquitos, Peru-Jaen and Cambodia (S1 and
S2). Similarly, except for the ELISA in Cambodia S2, the
specificity estimates for microscopy, ELISA and PCR were
significantly lower in Vietnam compared to the corresponding
ones in the other sites. The estimated true prevalence was
significantly higher in Vietnam than in the other 4 sites among
which Peru-Iquitos had the highest prevalence (Table 5).
A comparison between the ‘‘true’’ and apparent prevalence
provides the degree of bias when this is estimated with only one
diagnostic test. In Vietnam and Peru, microscopy was closer to the
‘‘true’’ estimate than the other 2 tests (Tables 3 and 5) while
ELISA, with its lower specificity, usually overestimated the true
infection prevalence (Table 5).
Discussion
An analysis of three tests for the detection of a malaria infection
and for estimating its prevalence was conducted using a Bayesian
framework. Bayesian techniques become exceedingly useful for
improved interpretation of diagnostic test performance in both the
medical and veterinary fields [26,27]. The Bayesian paradigm
clearly corresponds with the way of thinking of most scientists and
policy makers alike. Indeed, as results will never been interpreted
without any conscious or unconscious reflections, such a process is
formalized by a Bayesian framework. This is particularly useful in
the context of multiple diagnostic tests because it allows combining
different sources of information. A drawback of this approach is
the limited number of studies using several diagnostic tests.
However, within the Bayesian philosophy even the results of one
diagnostic test can be integrated in global estimations as far as the
uncertainty is properly acknowledged. It is important to notice that
the results (i.e. the true prevalence) depend on opinions obtained
from experts who need to be familiar with both malaria and the
tests used. In addition, the modelers need to known how to process
properly the prior information. Using Bayesian measures of
goodness-of-fit, i.e. the DIC and Bayes-p values appropriately
guarantee that the different parts of information (i.e., data and
expert opinion) are not conflicting, resulting in optimal estimates.
The approach corresponds with complex non-linear statistical
models where initial values are required. It should be noted that
the degree of freedom experts have in expressing opinions will
decrease with increasing number of diagnostic tests.
The characteristics of the diagnostic tests employed were
estimated without a gold standard. This contrasts with the
common practice of estimating the sensitivity and specificity of a
test by comparing its results with those obtained by microscopy
[13,14], an inappropriate reference [7,8]. In addition, both
sensitivity and specificity can be influenced by context-specific
factors.
The expert opinions originally provided for the 3 tests were not
in agreement with the data so that constrains (i.e. the level of
‘‘uncertainty’’) on the sensitivity of microscopy and ELISA in
Vietnam had to be relaxed. This adaptation allowed agreement
between prior information and actual data and resulted in a
significantly lower sensitivity for the microscopy in Vietnam
compared to the other regions, confirming the high variability of
this test’s sensitivity that depends both on the parasite density and
on the experience and skills of the slide reader. Indeed in Vietnam,
the parasite density is usually low and PCR data indicate a high
proportion of sub-patent infections, as well as mixed infections.
Therefore, sensitivity and specificity of a given test can vary
according to the setting and such variability can explain the wide
confidence intervals reported in other studies [9]. When including
in the analysis the variability of the tests’ sensitivity and specificity,
the malaria prevalence estimations are optimized and become
comparable across different settings, i.e. a site-specific analysis can
be done.
Table 3. Apparent prevalence figures of P. falciparum (exact
binomial 95% CI) for the different diagnostic tests by survey.
Sites Estimated prevalence % (95%CI)
Microscopy ELISA PCR
Vietnam 0.11 (0.10–0.12) 0.24 (0.22–0.26) 0.14 (0.12–0.15)
Peru (Iquitos) 0.04 (0.02–0.07) 0.14 (0.10–0.18) 0.03 (0.01–0.05)
Peru (Jaen) 0 (0–0.01) 0.11 (0.09–0.14) 0 (0–0.01)
Cambodia S1 0.04 (0.03–0.05) 0.11 (0.09–0.12) -
Cambodia S2 0.03 (0.02–0.04) 0.21 (0.19–0.24) -
ELISA=Enzyme-Linked Immunosorbent Assay; PCR=Polymerase Chain
Reaction; S1=survey 1; S2=survey 2.
doi:10.1371/journal.pone.0016705.t003
Table 4. Number of individuals according to the results of 2 or 3 diagnostic tests by survey.
Diagnostic tests Number of individuals
Microscopy ELISA PCR Vietnam Peru (Iquitos) Peru (Jaen) Cambodia S1 Cambodia S2
0 0 0 1530 292 447 1147 752
00 1 1 0 0 1 0
0 1 0 351 35 58 129 191
01 1 7 3 1 0
10 0 5 7 1 0 4 2 1 5
10 1 5 9 2 0
11 0 4 8 5 0 1 2 1 5
11 1 8 7 6 0
0=negative test result. 1=positive test result; number=number of individuals for each result category; S1=survey 1; S2=survey 2.
doi:10.1371/journal.pone.0016705.t004
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microscopy and PCR. This finding can be attributed to the
sampling of symptomatic patients in whom parasite density is
usually higher than in individuals, often healthy, selected
randomly for a population survey. The latter infections are
asymptomatic, hence with a lower parasite density, or even sub-
patent, i.e. undetectable by microscopy.
Combining several diagnostic tests does not imply that the
results of each separate test do not have any value. Although
positive serological tests may reflect persisting antibodies in non-
infected individuals, and hence the lower specificity, they have an
advantage of providing an indication of individuals having had a
past infection, a valuable information in areas where malaria
transmission is very low.
The approach based on the Bayesian framework may be useful
to re-examine data obtained with several malaria diagnostic tests
[32,33]. Estimating the malaria prevalence in a specific setting is
not straightforward, particularly when considering the lack of a
gold standard [9,34] and the variability of the diagnostic tests’
characteristics. A possible solution is combining the results
obtained with different tests. Indeed, assessing different diagnostic
techniques and estimating their sensitivity and specificity with the
assumption that none of them can provide perfect results can be
done through the integration of several sources of information.
Ochola and colleagues [9] were the first to point out the benefits of
combining results of several diagnostic tests for estimating malaria
prevalence. Nevertheless, the assumptions inherent to their
method are questionable [15], resulting in wide confidence
intervals that may in fact reflect real differences in the sensitivity
and specificity between different settings [9].
The recent shift from control to elimination with eventually
eradication as a goal will require a rigorous assessment of the
disease (i.e., infection) free state. Combining information from
different diagnostic tests may respond to this need and provide an
assessment on the uncertainty related to a disease (i.e., infection)
situation. Moreover, the approach based on the Bayesian
framework could be used for future studies and the obtained
‘‘latent’’ prevalence could then fit nicely within the global malaria
initiatives such as the malaria atlas project (MAP) [35], which is
already using the advantages of a Bayesian context. Indeed,
currently results are often not comparable from one location to
another because different diagnostics tests are used. Without a
gold standard, a standardized Bayesian approach for estimating
the ‘‘true’’ malaria prevalence can further strengthen the current
international efforts towards assessing and reducing the global
malaria burden.
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Table 5. Estimated prevalence and diagnostic tests’ sensitivity and specificity by survey.
Country Estimated true prevalence Estimated sensitivity and specificity
Microscopy ELISA PCR
se sp se sp se sp
Vietnam 0.12 0.53 0.95 0.55 0.80 0.95 0.97
CI lower 95% limit 0.01 0.42 0.94 0.42 0.78 0.89 0.95
CI upper 95% limit 0.15 0.70 0.96 0.70 0.82 1.00 1.00
Peru Iquitos 0.03 0.90 0.98 0.79 0.88 0.98 0.99
CI lower 95% limit 0.01 0.72 0.96 0.62 0.84 0.95 0.98
CI upper 95% limit 0.05 1.00 0.99 0.95 0.91 1.00 1.00
Peru Jaen 0.00 0.89 1.00 0.85 0.88 0.98 1.00
CI lower 95% limit 0.00 0.71 1.00 0.64 0.85 0.95 0.99
CI upper 95% limit 0.01 1.00 1.00 1.00 0.91 1.00 1.00
Cambodia S1 0.01 0.89 0.96 0.85 0.90
CI lower 95% limit 0.00 0.71 0.95 0.63 0.88
CI upper 95% limit 0.02 1.00 0.98 1.00 0.91
Cambodia S2 0.01 0.89 0.98 0.84 0.79
CI lower 95% limit 0.00 0.71 0.96 0.62 0.77
CI upper 95% limit 0.03 1.00 0.99 1.00 0.82
CI=credibility interval; Se=sensitivity; Sp=specificity; ELISA=Enzyme-Linked Immunosorbent Assay; PCR=Polymerase Chain Reaction; S1=survey 1; S2=survey 2.
doi:10.1371/journal.pone.0016705.t005
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